Targeted Oncology |
Experts Debate Need for New Drugs to Treat Patients with PV and ET
Targeted Oncology According to Al-Ali, current treatment guidelines for PV are based on the risk of thrombosis. She said she does not believe the current standard treatment options, such as phlebotomy and hydroxyurea, are able to abolish disease-related thrombotic events. |
from phlebotomy - Google News http://bit.ly/2dAiXWk
No comments:
Post a Comment